Nitinol Technologies CE-marks vena cava filter:
This article was originally published in Clinica
Nitinol Medical Technologies has CE-marked its Simon Nitinol vena cava filter. The thermal shape-memory filter is designed to prevent pulmonary embolism which occurs when a blood clot lodges in the vessels supplying blood to the lungs. The company, which estimated that the condition causes about 150,000 deaths each year in the US, claimed that the device holds the number two position in sales of vena cava filters worldwide.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in and interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.